Skip to content

Clinical trials

Glioblastoma trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Country / region: Japan Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20092
20131
20141
20151
20163
20172
20181
20191
20203
20212
20221
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Active, not recruiting3
Recruiting3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Bayer2
Eisai Co., Ltd.2
Eli Lilly and Company2
Sumitomo Pharma America, Inc.2
AbbVie1
AstraZeneca1
Canadian Cancer Trials Group1
EMD Serono Research & Development Institute, Inc.1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma22
Glioma11
Astrocytoma4
Brain Neoplasms4
Central Nervous System Neoplasms4
Oligodendroglioma3
Diffuse Intrinsic Pontine Glioma2
Ganglioglioma2
Ganglioneuroma2
Gliosarcoma2

Trials

Showing 51 to 22 of 22. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.